English
|
Spanish
Login
Register
The content on this site is intended for healthcare professionals only
For the latest
e
cancer COVID-19 resources, click on this link
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[503]
News
[1068]
Articles
[154]
Editorials
[8]
Conferences
[46]
e
learning
[8]
New discovery may pave the way for more targeted treatment of cancer patients
Pembrolizumab and lenvatinib receive positive EU CHMP opinions for two different types of cancer
FDA approves pembrolizumab combination for the first-line treatment of cervical cancer
OVANORDEST: Moroccan cancer research looks to improve survival in women with ovarian cancer
COVID-19 and cancer: Useful resources
High burden of liver, stomach and cervical cancers among the Hispanic/Latino population highlights a...
Innovative ovarian cancer research newly supported by R37 MERIT Award
FDA grants accelerated approval to tisotumab vedotin-tftv for recurrent or metastatic cervical cance...
ESMO 2021: Immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer
BAK/MCL1 complexes can predict chemotherapy drugs sensitivity in cancer cell
<
1
2
3
4
5
...
107
>
More from
e
cancer
